Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts. Jordan SC. Transplantation 2024 Sep 16. doi: 10.1097/TP.0000000000005206.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jordan SC. Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts. Transplantation 2024 Sep 16. doi: 10.1097/TP.0000000000005206.
PMID: 39279047